The Stronger Downregulation of in vitro and in vivo Innate Antiviral Responses by a Very Virulent Strain of Infectious Bursal Disease Virus (IBDV), Compared to a Classical Strain, Is Mediated, in Part, by the VP4 Protein by Dulwich, Katherine L et al.
ORIGINAL RESEARCH
published: 09 June 2020
doi: 10.3389/fcimb.2020.00315
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 June 2020 | Volume 10 | Article 315
Edited by:
Thirumala-Devi Kanneganti,
St. Jude Children’s Research Hospital,
United States
Reviewed by:
Rksubbarao Malireddi,
St. Jude Children’s Research Hospital,
United States
Xiaole Qi,
Harbin Veterinary Research Institute
(CAAS), China
*Correspondence:
Andrew J. Broadbent
andrew.broadbent@pirbright.ac.uk
Specialty section:
This article was submitted to
Microbes and Innate Immunity,
a section of the journal
Frontiers in Cellular and Infection
Microbiology
Received: 17 December 2019
Accepted: 25 May 2020
Published: 09 June 2020
Citation:
Dulwich KL, Asfor A, Gray A,
Giotis ES, Skinner MA and
Broadbent AJ (2020) The Stronger
Downregulation of in vitro and in vivo
Innate Antiviral Responses by a Very
Virulent Strain of Infectious Bursal
Disease Virus (IBDV), Compared to a
Classical Strain, Is Mediated, in Part,
by the VP4 Protein.
Front. Cell. Infect. Microbiol. 10:315.
doi: 10.3389/fcimb.2020.00315
The Stronger Downregulation of in
vitro and in vivo Innate Antiviral
Responses by a Very Virulent Strain
of Infectious Bursal Disease Virus
(IBDV), Compared to a Classical
Strain, Is Mediated, in Part, by the
VP4 Protein
Katherine L. Dulwich1,2, Amin Asfor 1, Alice Gray 1, Efstathios S. Giotis 2,3,
Michael A. Skinner 2 and Andrew J. Broadbent 1*
1 Birnaviruses Group, The Pirbright Institute, Woking, United Kingdom, 2 Department of Infectious Diseases, Imperial College
London, London, United Kingdom, 3 School of Life Sciences, University of Essex, Colchester, United Kingdom
IBDV is economically important to the poultry industry. Very virulent (vv) strains cause
higher mortality rates than other strains for reasons that remain poorly understood.
In order to provide more information on IBDV disease outcome, groups of chickens
(n = 18) were inoculated with the vv strain, UK661, or the classical strain, F52/70.
Birds infected with UK661 had a lower survival rate (50%) compared to F52/70 (80%).
There was no difference in peak viral replication in the bursa of Fabricius (BF), but the
expression of chicken IFNα, IFNβ, MX1, and IL-8 was significantly lower in the BF of birds
infected with UK661 compared to F52/70 (p < 0.05) as quantified by RTqPCR, and this
trend was also observed in DT40 cells infected with UK661 or F52/70 (p < 0.05). The
induction of expression of type I IFN in DF-1 cells stimulated with polyI:C (measured by an
IFN-β luciferase reporter assay) was significantly reduced in cells expressing ectopic VP4
from UK661 (p < 0.05), but was higher in cells expressing ectopic VP4 from F52/70.
Cells infected with a chimeric recombinant IBDV carrying the UK661-VP4 gene in the
background of PBG98, an attenuated vaccine strain that induces high levels of innate
responses (PBG98-VP4UK661) also showed a reduced level of IFNα and IL-8 compared
to cells infected with a chimeric virus carrying the F52/70-VP4 gene (PBG98-VP4F52/70)
(p < 0.01), and birds infected with PBG98-VP4UK661 also had a reduced expression
of IFNα in the BF compared to birds infected with PBG98-VP4F52/70 (p < 0.05). Taken
together, these data demonstrate that UK661 induced the expression of lower levels of
anti-viral type I IFN and proinflammatory genes than the classical strain in vitro and in vivo
and this was, in part, due to strain-dependent differences in the VP4 protein.
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INTRODUCTION
Infectious bursal disease virus (IBDV) is a highly contagious,
immunosuppressive virus belonging to the Birnaviridae family
(Hoerr, 2010). The virus is non-enveloped, with a bi-segmented
double stranded (ds) RNA genome encoding 3 open reading
frames (ORFs) which are translated and processed to produce
5 viral proteins (VP1-5). Ranking among the top five infectious
problems of chickens (Cazaban et al., 2017), IBDV poses a
continuous threat to the poultry industry though economic losses
and welfare concerns. Moreover, as the virus has a preferred
tropism for B cells, the majority of which reside in the bursa of
Fabricius (BF), surviving birds are often immunosuppressed, less
responsive to vaccination programmes, and more susceptible to
secondary infections (Giambrone, 1979; Spackman et al., 2018).
Disease severity depends on numerous factors including the
age and breed of the bird, and the virulence of the infecting IBDV
strain (Mahgoub et al., 2012). Since the first identification of
IBDV in the 1960s, classical (c) strains have circulated worldwide,
however, in the 1980s, so-called “very virulent” (vv) strains
emerged, complicating IBDV control efforts (Brown et al., 1994;
Brown and Skinner, 1996). The vvIBDV strains cause a far
higher mortality rate than classical strains, reaching up to 60–
70% in some flocks (van den Berg et al., 2000). However, the
molecular basis for the difference in disease outcome remains
poorly understood, although it has been demonstrated that both
segments A and B contribute to virulence (Escaffre et al., 2013).
Segment A encodes the non-structural protein, VP5, and a
polyprotein (VP2-VP4-VP3) which is co-translationally cleaved
by the protease, VP4 (Lejal et al., 2000). VP2 is the capsid
protein and VP3 is a multifunctional scaffolding protein that
binds the genome. The single ORF on Segment B encodes VP1,
the RNA-dependent RNA polymerase.
The innate immune response to IBDV infection is
characterized by the production of type I IFN responses,
including the upregulation of IFNα and IFNβ, that lead to the
induction of interferon stimulated genes (ISGs), including MX1,
which is one of the top ISGs identified in chicken cells ranked
by fold change (Giotis et al., 2017). The IFN response aims to
provide an antiviral state in infected and bystander cells. In
addition, pro-inflammatory cytokines, for example IL-6, IL-8,
and IL-1β are produced following IBDV infection that recruit
immune cells into the infected BF (Guo et al., 2012; Carballeda
et al., 2014; Quan et al., 2017; He et al., 2018).
We sought to identify IBDV virulence determinants in
order to better understand the molecular basis of phenotypic
differences between vv- and c-IBDV strains. Here we report that
vvIBDV UK661 down-regulated the expression of antiviral type
I IFN responses and pro-inflammatory cytokines compared to
cIBDV F52/70 in vitro and in vivo. Moreover, we demonstrate
that the differences in IFN antagonism were, in part, due to
strain-dependent differences in the VP4 proteins.
MATERIALS AND METHODS
Cells and Viruses
DF-1 cells (chicken embryonic fibroblast cells, ATCC number
CRL-12203) were sustained in Dulbecco’s modified Eagle’s
medium (DMEM) (Sigma-Aldrich, Merck, UK) supplemented
with 10% heat inactivated fetal bovine serum (hiFBS) (Gibco,
Thermo Fisher Scientific, UK) (Complete DMEM). DT40
cells (immortalized chicken B cell line, Baba et al., 1985)
were maintained in Roswell Park Memorial Institute (RPMI)
media supplemented with L-glutamine (Sigma-Aldrich, Merck),
sodium bicarbonate (Sigma-Aldrich, Merck) 10% hiFBS, tryptose
phosphate broth (Sigma-Aldrich, Merck) sodium pyruvate
(Gibco), and 50mM beta-mercaptoethanol (B-ME) (Gibco)
(complete RPMI media). A vv-strain, UK661 (Brown and
Skinner, 1996), and a c-strain, F52/70 (Bayliss et al., 1990) of
IBDV were kind gifts from Dr. Nicolas Eterradossi, ANSES,
France. Stocks of both viruses were generated by inoculating
3 week old specific pathogen free (SPF) Rhode Island Red
(RIR) chickens and harvesting the BF at 3 days post-infection.
BF tissue from 18 birds was pooled, homogenized, and the
homogenate mixed with Vertrel XF (Sigma-Aldrich, Merck)
and centrifuged at 1,200 g for 30min. The resulting aqueous
phase was harvested and frozen at −80◦C. The cell-culture
adapted vaccine strain, PBG98, and chimeric viruses within
the PBG98 backbone (PBG98-VP4UK661 and PBG98-VP4F52/70)
were propagated in DF-1 cells. Briefly, flasks of DF-1 cells were
inoculated with viruses and incubated until cytopathic effect
(cpe) was observed, whereupon the supernatant was harvested,
centrifuged at 1,200 rpm to pellet debris, and the supernatant was
aliquoted and frozen at−80◦C.
Virus Titration by TCID50
In order to titrate the UK661 and F52/70 viruses, 96-well U-
bottomed plates (Thermo Fisher Scientific) were seeded with the
immortal B cell line, DT40, at a seeding density of 1 × 104 cells
per well in 180 µL media. A 10-fold dilution series of the UK661
or F52/70 viruses was added to the cells, with 20 µL of each
dilution added to eachwell in quadruplicate. Cells were incubated
at 37◦C for 5 days, fixed in 4% paraformaldehyde and stained
with a primary mouse monoclonal antibody raised against IBDV
VP2 (Wark, 2000) and a secondary goat anti-mouse antibody
conjugated to Alexa Fluor 488 (Thermo Fisher Scientific). Wells
were marked positive or negative for the presence or absence of
virus by immunofluorescence microscopy and the TCID50/mL
calculated by the Reed and Muench method (Reed and Muench,
1938). In order to titrate the PBG98 and chimeric viruses, 96-well
plates were seeded with DF-1 cells at a density of 1 × 104 cells
per well in 180 µL media. A 10-fold dilution series of the PBG98
or chimeric viruses were added to the cells, with 20 µL of each
dilution added to eachwell in quadruplicate. Cells were incubated
at 37◦C for 5 days, and wells were marked positive or negative for
the presence or absence of cpe and the TCID50/mL calculated by
the Reed and Muench method (Reed and Muench, 1938).
F52/70 and UK661 In vivo Study
Forty-two SPF RIR chickens of mixed gender were obtained
from the National Avian Research Facility (NARF) and reared at
The Pirbright Institute. Chickens were randomly designated into
mock-infected (n = 6), F52/70-infected (n = 18) and UK661-
infected (n= 18) groups. At 3 weeks of age, birds were inoculated
with either PBS or a virus dose of 1.8 × 103 TCID50/bird,
delivered intranasally, 50 µL per nares. Clinical scores were
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recorded at least twice daily according to a points-based scoring
system (Supplementary Figure 1) that characterized disease as
mild (1–7), moderate (8–11), or severe (12–17). The scoring
system was developed at The Pirbright Institute and approved
by the Home Office (Project License number 7008981). Briefly,
birds were scored on their appearance, behavior with and without
provocation and handling, and included an assessment of the
wattles, combs, feathers, eyes, posture, breathing, interactions
with the rest of the flock, ability to evade capture, weight,
and crop palpation. Six birds from each infected group were
humanely culled by cervical dislocation at the time points
indicated, or when the humane end point (a score of 11)
was reached, and tissues were harvested at post-mortem for
downstream analysis. The BF was harvested from each bird and
divided into two sections, one stored in RNAlater (Thermo Fisher
Scientific) for RNA extraction and one snap frozen on dry ice for
virus titration by TCID50. All animal procedures conformed to
the United Kingdom Animal (Scientific Procedures) Act (ASPA)
1986 under Home Office Establishment, Personal and Project
licenses, following approval of the internal Animal Welfare and
Ethic Review Board (AWERB) at The Pirbright Institute.
PBG98, PBG98-VP4F52/70, and
PBG98-VP4UK661 In vivo Study
Seventy-two SPF RIR chickens of mixed gender were obtained
from the NARF and reared at The Pirbright Institute.
Chickens were randomly divided into mock-infected (n = 18),
recombinant wild-type (wt) PBG98-infected (n = 18), PBG98-
VP4F52/70-infected (n = 18), and PBG98-VP4UK661-infected (n
= 18) groups. At 3 weeks of age, birds were inoculated with
either PBS or a virus dose of 1.8 × 103 TCID50/bird, delivered
intranasally, 50 µL per nares. Clinical scores were recorded at
least twice daily according to the points-based scoring system
(Supplementary Figure 1). Six birds from each infected group
were humanely culled at 2, 4, and 14 days post-infection and the
BF was harvested from each bird and divided into two sections,
one stored in RNAlater (Thermo Fisher Scientific) for RNA
extraction and one snap frozen on dry ice. All animal procedures
conformed to the United Kingdom ASPA 1986 under Home
Office Establishment, Personal and Project licenses, following
approval of the internal AWERB at The Pirbright Institute.
RNA Extraction, RT, and qPCR
RNA was extracted from 30mg of homogenized bursal tissue,
or from cells in tissue culture wells, using the Monarch Total
RNA Miniprep Kit (NEB) according to the manufacturer’s
instructions. Complementary DNA (cDNA) was generated
using SuperScript III Reverse Transcriptase (Invitrogen). The
reaction constituents and conditions were consistent with
the manufacturer’s instructions. For virus quantification,
qPCR was performed using TaqManTM Universal qPCR
Master Mix (Applied Biosystems) according to manufacturer’s
instructions. Amplification and detection of targeted genes was
performed with the QuantStudioTM 5 (Applied Biosystems)
with the following cycling conditions: 50◦C for 5min, 95◦C
for 2min, 40◦C cycles of 95◦C for 3 s, and 60◦C for 30 s.
For quantification of host genes, a SYBR green qPCR
was performed using Luna R⃝ Universal qPCR mix (NEB)
according to manufacturer’s instructions. Amplification
and detection of targeted genes was performed with the
QuantStudioTM 5 (Applied Biosystems) with the following
cycling conditions: 95◦C for 20 s, 40 cycles of 95◦C for 1 s,
and 60◦C for 20 s, then a melt curve step at 95◦C for 1 s,
60◦C for 20 s, and 95◦C for 1 s. Primers for all qPCR reactions
can be found in Supplementary Table 1. CT values were first
normalized to a housekeeping gene (RPLPO) and then to
mock inoculated controls and expressed as fold change in a
!!CT analysis.
In vitro IBDV Infection
DF-1 cells were seeded into 24-well plates at 1.5 × 105/well
and incubated at 37◦C overnight to allow adhesion. Virus
stocks were diluted in complete DMEM media to the specified
multiplicity of infection (MOI) and added to the cells. DT40
cell suspensions were counted, pelleted and resuspended in
a solution of virus diluted in complete RPMI media at the
specified MOI. Cells were incubated for 1 h at 37◦C and
5% CO2. After incubation, the inoculum was removed from
the cells and cells were washed with fresh media before
incubation in fresh media at 37◦C and 5% CO2 until the desired
time point.
Luciferase Assays for IFNβ
VP4 expression plasmids were designed and synthesized with
the gene encoding a chicken codon-optimized enhanced (e)
GFP tag at the 5′ end of the VP4 nucleotide sequence. DF-
1 cells were seeded into a 24-well plate at a density of 1.5 ×
105 cells/ well and incubated for 24 h at 37◦C and 5% CO2
until 80% confluency. Cells were transfected with expression
plasmids using LipofectamineTM 2000 (Invitrogen) according to
the manufacturer’s instructions. A final concentration of 500 ng
plasmid per well was used following optimization experiments.
Briefly, cells were co-transfected with 40 ng Renilla luciferase,
80 ng of a pGL3 Luciferase reporter plasmid containing the
promoter regions of IFNβ upstream of a Firefly luciferase
gene to measure type I IFN induction (a kind gift from
Steve Goodbourn of St. George’s, University of London) and
500 ng of eGFP or eGFP-tagged VP4 expression plasmids.
Twenty four hours post-transfection, transfection efficiency was
confirmed by immunofluorescence microscopy, and protein
was extracted from parallel wells for western blot analysis.
IFNβ production was stimulated by transfecting cells with
(10µg/mL) polyinosinic: polycytidylic acid (poly I:C) (Sigma
Aldrich, Merck). Cells were lysed 6 hours after poly I:C
transfection using 100 µL 1X passive lysis buffer (Promega).
Plates were frozen for at least 30min at −80◦C before thawing
and reading on a GloMax Multi plate reader (Promega). Briefly,
once thawed, 10 µL of the sample was added in triplicate to
a 96 well opaque white plate (Pierce) and analyzed on the
plate reader using Stop and Glo reagents (Promega) according
to the manufacturer’s instructions. Firefly and Renilla values
were recorded and Firefly luciferase values were normalized to
Renilla values.
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Western Blot
Cells were lysed in Laemmli Sample buffer (BIO-RAD)
containing B-ME, heated to 95◦C for 5min, and disrupted
by sonication. Samples were subject to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using
a Mini-PROTEAN tetra vertical electrophoresis chamber
(BIO-RAD) and transferred to a nitrocellulose membrane
using a Trans-Blot Turbo Transfer System (BIO-RAD).
Membranes were stained with rabbit anti-VP4 [a gift
from Jóse Castón of Centro Nacional de Biotecnología
(CNB-CSIC)] and mouse anti-βactin (Thermo Fisher
Scientific), followed by donkey anti-rabbit-680 and donkey
anti-mouse-800 (LI-COR) and imaged with an Odyssey
CLx (LI-COR).
Generation of Chimeric VP4 Viruses
A reverse genetics system for the cell-adapted (ca-)IBDV
vaccine strain PBG98 was developed in house (Campbell
et al., 2020). Briefly, the sequences of PBG98 segments
A and B (Genbank Accession Numbers: MT010364 and
MT010365) including the 5′ and 3′ non-coding regions were
flanked by self-cleaving ribozymes (a hammerhead ribozyme
upstream and a hepatitis delta ribozyme downstream, Chowrira
et al., 1994). The whole sequence was ordered (GeneArt,
ThermoFisher Scientific, UK) and cloned into a pSF-CAG-
KAN vector (Sigma-Aldrich, Merck, UK) using restriction
enzyme pairs Kpn1/ Nhe1 (Segment A) and Sac1/Xho1 (Segment
B) (New England Biosciences, UK) to make two “reverse
genetics” plasmids (pRGs), pRG-PBG98-A, and pRG-PBG98-
B. DF-1 cells at 70% confluency were transfected with both
plasmids with lipofectamine 2000 (Invitrogen, ThermoFisher
scientific, UK) in order to rescue the recombinant PBG98
virus. Genestrings were synthesized for the PBG98 segment
A, replacing the VP4 sequence with that of UK661 or
F52/70 (PBG98-VP4UK661 and PBG98-VP4F52/70, respectively)
(GeneArt, Thermo Fisher). Genestrings were digested using
KpnI and NheI and ligated into the pSF-CAG-KAN vector to
make the “reverse genetics” plasmids pRG-PBG98-VP4UK661 or
pRG-PBG98-VP4F52/70. These plasmids were transfected into
DF-1 cells with pRG-PBG98-B in order to rescue the PBG98-
VP4UK661 and PBG98-VP4F52/70 viruses. Transfected DF-1 cells
were incubated until cytopathic effect (cpe) was observed, after
which the virus-containing supernatants were passaged onto
additional DF-1 cells to generate viral stocks. The sequence of
the VP4 gene was determined by Sanger sequencing all recovered
recombinant viruses.
Statistical Analysis
Statistical significance between experimental groups
was determined following a Shapiro-Wilk normality
test to confirm whether the data followed a normal
distribution for parametric or non-parametric testing, and
a one-way ANOVA with Tukey’s multiple comparison
test on fold change values was performed, using
Minitab (v.18). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
∗∗∗∗p< 0.0001.
RESULTS
UK661 Was More Virulent Than F52/70 but
Both Replicated to the Same In vivo Peak
Titer
Groups of 18 chickens were either inoculated with UK661
or F52/70, and 6 chickens were mock-inoculated with PBS
alone. Birds were assessed clinically at least twice daily, and
humanely culled when humane end-points were reached. At 24
and 48 h post-infection (hpi), 6 birds per infected group were
humanely culled and the BF harvested for quantification of
viral replication and host gene expression. At 54 hpi, 3 of the
remaining 6 (50%) birds inoculated with UK661 reached their
humane end-points and were humanely culled, compared to 1/6
(17%) of birds inoculated with F52/70 (Figure 1A), consistent
with UK661 being more virulent than F52/70, as expected. The
remaining infected and mock-inoculated birds were humanely
culled at 72 hpi. There was no statistically significant difference
in the BF: body weight ratio (BF:BW) between groups of birds
(Supplementary Figure 2), a metric that is sometimes used as
a surrogate of bursal pathology (Mase and Oishi, 1986; Cloud
et al., 1992). Moreover, the kinetics of disease progression
was similar between the two viral strains, peaking at 54 hpi
(Figure 1B), and there was no significant difference in the fold
change in viral transcripts measured by RTqPCR between the
two strains at any of the time points measured (Figure 1C). We
also determined the viral titers in the bursal tissue at each time
point by TCID50, and although we found UK661 replicated to
a lower titer than F52/70 at 24 hpi (∗P < 0.05), there was no
significant difference in viral replication at later time points,
which peaked at ∼8 log10 TCID50/g of bursal tissue for both
strains (Figure 1D).
The Expression of Type I IFN and
Pro-inflammatory Genes Was Significantly
Reduced in BF Tissue Harvested From
Birds Infected With Strain UK661
Compared to Strain F52/70 In vivo
RNA was extracted from BF samples and reverse transcribed
to cDNA that was used as the template in qPCR assays
targeting chicken type I IFN genes IFNα, IFNβ and Mx1,
and pro-inflammatory cytokines IL-6, IL-8, and IL-1β. These
genes were selected as they are the most relevant to studying
antiviral type I IFN and pro-inflammatory responses, and
have previously been shown to be upregulated following IBDV
infection (Guo et al., 2012; Carballeda et al., 2014; Giotis
et al., 2017; Quan et al., 2017; He et al., 2018). The mean
expression of IFNα (Figure 2A), IFNβ (Figure 2B), and Mx1
(Figure 2C) was lower in BF samples harvested from UK661-
infected birds compared to F52/70-infected birds at 24 and 48 h
post-inoculation, which was statistically significant for IFNβ at
48 hpi and Mx1 at 24, 48, and 72 hpi (∗P < 0.05). There
was no significant difference in the mean expression of IL-1β
(Figure 2D) or IL-6 (Figure 2E) between birds infected with the
two strains, but IL-8 was significantly reduced in BF samples
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FIGURE 1 | The UK661 strain was more virulent than the F52/70 strain, but both strains replicated to the same peak titer in vivo. Birds were checked twice daily by
two independent observers for clinical signs and a Kaplan Meier survival curve plotted of mock- (black), F52/70- (pink), and UK661- (gray) inoculated birds that
reached their humane end points (clinical score of 11) (A). Clinical signs were quantified by a scoring system and divided into mild (1-7) and moderate (8-11). Each
bird was assigned a clinical score at the indicated time points post-infection (B). Six birds per group were humanely culled at 24 and 48 h post-infection (hpi), one
F52/70 and three UK661-infected birds reached their humane end-points at 54 hpi and the remaining birds were culled at 72 hpi. The bursa of Fabricius was
harvested at necropsy and the log10 fold change in viral RNA copies/g tissue determined by RT-qPCR (C). The infectious titer was determined by titration onto DT40
cells in the method described by Reed and Muench. Virus titers were expressed as log10 TCID50/g of tissue (D). The horizontal lines are the mean values. Data
passed a Shapiro-Wilk normality test before being analyzed by a one-way ANOVA and a Tukey’s multiple comparison test (**p < 0.01).
harvested from UK661-infected birds compared to F52/70-
infected birds at 48 and 72 h post-inoculation (∗P < 0.05)
(Figure 2F). Taken together, these data demonstrate that the
expression of antiviral type I IFN responses (IFNβ and Mx1)
and pro-inflammatory cytokine responses (IL-8) in the BF was
reduced following infection with the vv strain compared to the
classical strain.
The Expression of Type I IFN and
Pro-inflammatory Genes Was Significantly
Reduced in B Cells Infected With UK661
Compared to F52/70 In vitro
We compared the replication of UK661 and F52/70 and the
expression of type I IFN and proinflammatory cytokines in DT40
cells, an immortalized avian B cell-line. Cells were infected with
UK661 or F52/70 (MOI 0.1) and the expression of virus and
host-cell transcripts quantified by RTqPCR at 14, 48, and 72
hpi. UK661 replicated to a significantly higher titer than F52/70
across all time points (∗∗∗P < 0.001) (Figure 3A). However, cells
infected with UK661 showed significantly reduced expression
of IFNα, IFNβ, and Mx1 compared to cells infected with
F52/70 at 14, 48, and 72 hpi (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P <
0.001) (Figures 3B–D). Expression of IL-1β and IL-6 was also
significantly reduced in cells infected with UK661 compared
to F52/70 at multiple time-points (∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001) (Figures 3E,F). In contrast, IL-8 expression was
significantly higher in cells infected with UK661 than F52/70
at 48 hpi (∗∗∗P < 0.01) (Figure 3G). Taken together, these
data suggest that the vv strain is able to reduce the expression
of mRNAs for IFNα, IFNβ, Mx1, and the pro-inflammatory
cytokines IL-1β and IL-6 to a greater extent than the classical
strain in vitro, confirming our in vivo data.
The UK661-, but Not F52/70-, VP4 Protein
Antagonized IFNβ Induction In vitro
The VP4 protein of IBDV has previously been identified as an
IFN antagonist (Li et al., 2013). We hypothesized that strain-
dependent differences in the VP4 proteins would be responsible
for the observed differences in type I IFN responses between the
strains. In order to address this, VP4 sequences across groups of
very virulent, classical, and attenuated/cell-adapted IBDV strains
available on the NCBI database were aligned using Clustal Omega
(Sievers et al., 2011) (Supplementary Figure 3A). Compared to
F52/70 VP4, there were 9 amino acids different in the UK661 VP4
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FIGURE 2 | The expression of type I IFN and pro-inflammatory genes was significantly reduced in BF tissue harvested from birds infected with strain UK661
compared to strain F52/70 in vivo. The bursa of Fabricius was harvested from mock and infected birds at necropsy and RNA extracted. RNA was reverse transcribed
and amplified by quantitative PCR using specific primer sets for target genes. IFNα (A), IFNβ (B), Mx1 (C), IL-1β (D), IL-6 (E), and IL8 (F). The CT values were
normalized to the housekeeping gene RPLPO and the log2 fold change in gene expression determined for the infected samples relative to the mock-infected samples
in a !!CT analysis and plotted for individual birds. The horizontal lines are the mean values. Data are representative of at least three replicate experiments and
passed a Shapiro-Wilk normality test before being analyzed by a one-way ANOVA and a Tukey’s multiple comparison test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p
< 0.0001). The dashed horizontal line represents the cut-off, below which genes were significantly down-regulated compared to mock-inoculated birds.
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FIGURE 3 | The expression of type I IFN and pro-inflammatory genes was significantly reduced in B cells infected with strain UK661 compared to strain F52/70 in
vitro. DT40 Cells were infected at an MOI of 0.1 with either the UK661 or F52/70 IBDV strains, or mock-infected with media alone and RNA was extracted from the
(Continued)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 June 2020 | Volume 10 | Article 315
Dulwich et al. IBDV Inhibition of Innate Immunity
FIGURE 3 | cells at the indicated time points post-infection. RNA was reverse transcribed and amplified by qPCR using specific primer sets. The CT values were
normalized to the housekeeping gene RPLPO and the log10 fold change in virus gene expression determined for the infected samples relative to the mock-infected
samples in a !!CT analysis and plotted (A). The log2 fold change in host-cell gene expression was also determined for the infected samples relative to the
mock-infected samples in a !!CT analysis and plotted (B–G). Data subsequently passed a Shapiro-Wilk normality test before being analyzed by a one-way ANOVA
and a Tukey’s multiple comparison test (*P < 0.05) (A), or a two-tailed unpaired Student’s t-test (*p < 0.05, ***p < 0.001). Data shown are representative of at least
three replicate experiments, columns represent the mean values, and error bars represent the standard deviation of the mean.
protein (V31I, D114V, D122G, R132K, N141S, C170Y, K175N,
P205S, and H241D). Interestingly, 5 of these were also found in
other vv strains, from diverse geographical regions, but not in
classical or vaccine strains (31I, 170Y, 175N, 205S, and 241D).
The VP4 protein structures were modeled (using PyMOL version
2.0, Schrödinger, LLC) to the known VP4 structure of another
member of the Birnaviridae family, the Yellowtail Ascites Virus
(YAV; 4izk.2.A) (Supplementary Figure 3B), as the structure of
IBDV VP4 protein remains unsolved at the time of writing.
The YAV VP4 sequence shares 24.75% amino acid identity and
lacks the last 25 amino acids of the IBDV sequence so the
amino acid at position 241 is absent. Nevertheless, based on this
model, the amino acid differences between the two VP4 proteins
were found to cause some alterations in the predicted secondary
structure, for example the presence of β-strands in the UK661
VP4 molecule that were not seen in the F52/70 VP4 molecule
(Supplementary Figure 3B, dashed boxed regions).
To determine whether the VP4 proteins from UK661 and
F52/70 IBDV inhibited IFNβ induction, we co-transfected DF-
1 cells with an IFNβ luciferase reporter plasmid and plasmids
encoding VP4 proteins from either UK661 or F52/70, tagged
with enhanced GFP (eGFP) at the N-terminus (eGFP-UK661-
VP4 and eGFP-F52/70-VP4). The eGFP tag was used to monitor
transfection efficiency. Transfected cells were stimulated with
poly I:C to induce the production of IFNβ that was quantified
by measuring Firefly luciferase units normalized to Renilla
luciferase. A low level of IFNβ induction was observed in all
groups in the absence of poly I:C stimulation, with little difference
between those transfected with the VP4 expression plasmids
and a plasmid expressing eGFP alone (vector control plasmid)
(Figure 4). In contrast, upon stimulation with poly I:C, there was
an increase in IFNβ induction in cells expressing eGFP alone
that was significantly reduced in cells expressing eGFP-UK661-
VP4 (∗∗P< 0.01). This reduction was not seen in cells expressing
eGFP-F52/70-VP4, despite more protein detected by western blot
than eGFP-UK661-VP4. In fact, there was a significant increase
in IFNβ induction compared to cells expressing either eGFP-
UK661-VP4 or eGFP alone (∗∗P< 0.01). These data demonstrate
that the VP4 protein from the vv IBDV strain down-regulates
IFNβ induction in vitro, but the VP4 protein from the classical
strain does not.
The Ability of the UK661 VP4 Protein to
Antagonize Type I IFN Responses Was
Reduced in the Context of the Whole Virus
In vitro and In vivo
In order to determine the extent to which strain dependent
differences in the VP4 protein antagonized type I IFN responses
FIGURE 4 | The VP4 protein from the UK661 strain antagonized IFNβ
induction, but the VP4 protein from the F52/70 strain did not in vitro. DF-1s
were transfected with the chicken IFNβ promoter Firefly luciferase reporter and
a constitutively active Renilla expression plasmid and 500 ng of either
eGFP-UK661-VP4 or eGFP-F52/70-VP4 expression plasmids, or a control
plasmid expressing eGFP alone. Twenty-four hours post-transfection, cells
were re-transfected with poly I:C. At 6 h post-transfection, cells were lysed and
luciferase activity quantified. Firefly luciferase activity was normalized to Renilla
expression. Data presented are the means of three independent experiments
and passed a Shapiro-Wilk normality test before being analyzed by a one-way
ANOVA and a Tukey’s multiple comparison test (*p < 0.05, **p < 0.01). Error
bars represent the standard error of the mean (SEM). In a parallel experiment,
transfected cells were lysed and samples denatured and subject to SDS-PAGE
gel electrophoresis followed by transfer to a nitrocellulose membrane and
staining with anti-VP4 and anti-β-actin antibodies in a western blot.
in the context of a whole virus, chimeric viruses were generated
with the VP4 gene from either the UK661 or F52/70 strains
in the backbone of a highly attenuated cell culture-adapted
vaccine strain, PBG98 (PBG98-VP4UK661 and PBG98-VP4F52/70,
respectively). DF-1 cells were infected with recombinant chimeric
or wt PBG98 viruses (MOI 1) and RNA was extracted, reverse
transcribed and the fold change in viral RNA quantified by
qPCR at several time points post-infection. All viruses replicated
to a maximum of 104-105 fold change in viral RNA per mL
supernatant, with no significant differences in viral replication
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FIGURE 5 | The PBG98-VP4 UK661 virus inhibits the induction of IFNα and IL-8 to a greater extent than the PBG98-VP4F52/70 virus in vitro. DF-1 cells were infected
with PBG98, PBG98-VP4UK661, and PBG98-VP4F52/70 viruses at an MOI of 1, before RNA was extracted at the indicated time points post-infection and reverse
(Continued)
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FIGURE 5 | transcribed. Virus specific primers were used to amplify the cDNA by quantitative (q)PCR, the CT values were normalized to the housekeeping gene
RPLPO and the log10 fold change in virus gene expression was determined for the infected samples relative to the mock-infected controls in a !!CT analysis and
plotted. A one-way ANOVA and a Tukey’s multiple comparison test was performed where no significant difference was found at any time point between the three
viruses (A). A panel of genes, IFNα (B), IFNβ (C), Mx1 (D), IL-1β (E), and IL-8 (F), were amplified by qPCR using specific primer sets for target genes, before the CT
values were normalized to the housekeeping gene RPLPO and the log2 fold change in gene expression determined for the infected samples relative to the
mock-infected controls in a !!CT analysis and plotted. Data are representative of at least three replicate experiments and passed a Shapiro-Wilk normality test before
being analyzed by a one-way ANOVA and a Tukey’s multiple comparison test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). The mean values are plotted and
the error bars are the standard error of the mean (SEM). The dashed horizontal line represents the cut-off, below which genes were significantly down-regulated.
kinetics (Figure 5A). Consistent with our previous observations,
the expression of IFNα was significantly reduced in cells infected
with the PBG98-VP4UK661 virus compared to cells infected with
the PBG98-VP4F52/70 virus at 24 hpi (Figure 5B), and, although
not statistically significant, the same trend was observed 24 hpi
for IFNβ and Mx1 (Figures 5C,D). Interestingly, by 24 hpi,
both chimeric viruses induced elevated IFNβ compared to the
recombinant wt PBG98 virus. In addition, by 24 hpi, the PBG98-
VP4UK661 virus induced a lower level of expression of IL-1β and
IL-8 than the PBG98-VP4F52/70 virus, which reached statistical
significance for IL-8 (∗∗∗∗P < 0.0001). These data demonstrate
that although the replication titers of the two chimeric viruses
were similar, the expression of type I IFNα and pro-inflammatory
cytokine IL-8 was lower during infection with the PBG98-
VP4UK661 virus compared to the PBG98-VP4F52/70 virus. This
suggests that differences in the inhibition of innate immune
responses is likely due to an intrinsic difference in the sequence
of the VP4s, rather than due to different amounts of the protein
being produced.
To compare virus replication kinetics and host gene
expression in vivo, groups of 18 chickens were inoculated with
chimeric and wt PBG98 viruses, or mock inoculated with buffer
alone. At 2, 4 and 14 days post-inoculation, the BFs were
harvested, RNA was extracted and the expression of IBDV,
IFNα, IFNβ, Mx1, IL-6, IL-8, and IL-1β quantified by RTqPCR.
There was no significant difference in viral replication between
any of the groups (Figure 6A). However, virus replication was
somewhat low (up to 103 fold change in viral RNA per gram
of BF tissue), possibly due to the cell-culture adapted nature
of the backbone. Consistent with our previous observations, at
day 2 post-inoculation, the expression of IFNα was significantly
lower in the BF of birds infected with the PBG98-VP4UK661
virus compared to the PBG98-VP4F52/70 virus (∗P < 0.05)
(Figure 6B). This trend was the same at day 4 post-inoculation
although this did not reach statistical significance. Likewise,
the average IFNβ expression at day 4 post-inoculation was
lower in the BF of birds infected with the PBG98-VP4UK661
virus compared to the PBG98-VP4F52/70 virus, but this did not
reach statistical significance (Figure 6C). Mx1 expression was
similar in birds infected with PBG98 and the chimeric viruses at
days 2 and 4 post-inoculation (Figure 6D). Comparing the pro-
inflammatory response between these viruses, IL-1β expression
was significantly lower in the BFs of birds inoculated with either
of the chimeric viruses at 2 days post-inoculation compared to
recombinant wt PBG98 (∗∗∗P < 0.001) (Figure 6E), but there
was no significant difference in IL-8 expression between any
of the virus groups at day 2 or 4 post-inoculation (Figure 6F).
Taken together, these data demonstrate that the chimeric virus
containing the VP4 gene from the vvIBDV strain UK661 induced
a lower level of type I IFNα compared to the chimeric virus
containing the VP4 gene from the cIBDV strain F52/70 both
in vitro and in vivo. However, the effect of the VP4 protein on
IFNβ, Mx1, or pro-inflammatory cytokines was reduced in the
context of virus infection, compared to ectopic expression.
DISCUSSION
Very virulent strains of IBDV emerged in the 1980s, causing up
to 60% mortality in some commercial flocks (van den Berg et al.,
2000). However, the molecular basis for this increased virulence
remains poorly understood (Chettle et al., 1989; Nunoya et al.,
1992). We have previously shown that the vvIBDV UK661 was
able to down-regulate type I IFN and a selection of ISGs to
a greater extent than a vaccine strain, D78, in primary B cells
cultured and infected ex vivo (Dulwich et al., 2017). Here, we
extend these observations by demonstrating that UK661 is also
able to down-regulate type I IFN and pro-inflammatory cytokine
responses compared to a classical field strain, and we confirm that
this occurs not only in vitro, but also in vivo (Figures 2, 3).
Other studies have compared strain-dependent differences
in innate immune responses to IBDV infection, however, the
majority have compared vv strains with cell culture adapted
(ca) strains. For example, He et al. found TLR3, IL-8, and
IFNβ expression were more up-regulated in response to the
vvIBDV strain than a vaccine strain, and Liu et al. found
elevated expression of cytokines following vvIBDV infection
compared to a vaccine strain, however the vv strain replicated to
significantly higher titers that the vaccine strains in both studies,
making comparison of gene expression changes challenging
(Liu et al., 2010; He et al., 2017). In contrast, in our study,
there was no significant difference in peak virus replication
between the F52/70 and UK661 strains, meaning that differences
in gene expression are due to factors unrelated to viral load.
Unfortunately, some studies comparing the innate immune
response following vvIBDV infection to caIBDV strains also
inoculated birds with different amounts of virus, making a direct
comparison of gene expression difficult (Yu et al., 2015). To
our knowledge, only one previous study, by Eldaghayes et al.,
has compared classical and vvIBDV strains in vivo (Eldaghayes
et al., 2006). Our data are consistent with this work, which also
reported that a vv IBDV strain induced reduced type I IFN
responses compared to a classical strain. However, the authors
conducted two separate in vivo studies, one with each virus, and
did not compare the two viruses in the same study. Moreover,
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FIGURE 6 | The PBG98-VP4 UK661 virus inhibits the induction of IFNα to a greater extent than the PBG98-VP4F52/70 virus in vivo. Birds were inoculated with 1.8 ×
103 TCID50 of the PBG98, PBG98-VP4UK661, and PBG98-VP4F52/70 viruses, and the bursa of Fabricius was harvested at necropsy from 6 birds per group at 2, 4, and
(Continued)
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FIGURE 6 | 14 days post-inoculation. RNA was extracted prior to reverse transcription to cDNA and qPCR amplification with virus-specific primers. CT values were
normalized to a housekeeping gene and expressed as log10fold change viral RNA relative to mock-infected samples as per the !!CT method. The data passed a
Shapiro-Wilk normality test before being analyzed by a one-way ANOVA and a Tukey’s multiple comparison test (not significant) (A). At 2 and 4 days post-inoculation,
cDNA was amplified by qPCR for a panel genes: IFNα (B), IFNβ (C), Mx1 (D), IL-1β (E), and IL-8 (F). The CT values were normalized to the housekeeping gene
RPLPO and expressed relative to mock-infected samples using the !!CT method. Data are representative of at least three replicate experiments and passed a
Shapiro-Wilk normality test before being analyzed by a one-way ANOVA and a Tukey’s multiple comparison test (*p < 0.05, ***p < 0.001). Horizontal lines represent
the mean and error bars represent the standard error of the mean (SEM).
birds were inoculated with a different dose of each virus, making
a comparison of gene expression challenging. We extend these
observations by directly comparing the vv and classical strains in
the same in vivo study, in birds inoculated with the same dose of
each virus.
We also demonstrate that the differences in IFN antagonism
are, in part, due to strain-dependent differences in the VP4
proteins (Figures 4–6). The VP4 protein from vvIBDV strain Lx
has previously been shown to act as an IFN antagonist through an
interaction with the host glucocorticoid-induced leucine zipper
(GILZ) protein (Li et al., 2013; He et al., 2018). GILZ plays a
key role in the regulation of NF-κB activation by binding to the
p65 subunit and preventing its translocation into the nucleus
and the downstream expression of cytokines (Di Marco et al.,
2007). The Lx VP4 protein has been shown to bind to GILZ,
preventing its ubiquitination and degradation, resulting in its
accumulation in the cytoplasm. Consequently, the VP4-GILZ
interaction reduces p65 translocation into the nucleus, leading
to a reduction in the expression of pro-inflammatory cytokines
and type I IFN responses (He et al., 2018). We extend these
observations by demonstrating that there are strain dependent
differences in the extent to which VP4 antagonizes type I IFN
induction. Elucidating differences in the mechanism of action of
the different VP4 proteins was beyond the scope of this study,
however, the amino acid sequence of the UK661 VP4 is the same
as the Lx VP4, meaning that the UK661 VP4 will bind GILZ and
inhibit NF-κB activation, whereas it is possible the affinity of the
F52/70 VP4 for GILZmay be reduced. We speculate that the VP4
proteins of vv IBDV strains have a higher affinity for binding
GILZ than the VP4 proteins of less virulent strains, meaning
the vv IBDV strains may be able to inhibit NF-κB activation to
a greater extent than less virulent strains. As NF-κB activation
is partly responsible for the induction of antiviral type I IFN
responses and pro-inflammatory cytokine responses, this model
is consistent with our observations.
We demonstrated the involvement of the VP4 protein in
the antagonism of type I IFN responses both by luciferase
reporter assay, and the use of chimeric viruses expressing the VP4
protein from either UK661 or F52/70. However, the phenotype
we observed with the chimeric viruses was less pronounced
than that observed by luciferase reporter assay as, while the
PBG98-VP4UK661 virus induced lower levels of IFNα, IFNβ, and
Mx1 than the PBG98-VP4F52/70 virus in vitro, this only reached
statistical significance for IFNα at 24 hpi. This suggests that the
VP4 gene is not the sole determinant of the difference in type I
IFN responses observed between the UK661 and F52/70 viruses.
Other IBDV proteins have previously been implicated in the
inhibition of type I IFN responses, for example the VP3 protein
is known to bind the dsRNA genome of IBDV and competitively
inhibit detection byMDA5, preventing the downstream signaling
of the IFN pathway and the production of type I IFN (Ye et al.,
2014), and it is likely that multiple genes work in concert to
produce the observed phenotypes.
When the chimeric viruses were inoculated into chickens,
both replicated to low titers and caused few clinical signs, most
likely because these viruses possess the backbone of a cell culture
adapted, highly attenuated virus. We were therefore unable to
ascertain whether strain-dependent differences in VP4 affected
IBDV virulence. Previous studies, using chimeric viruses with
segments A and B from strains of differing virulence, found that
both segments contributed to virulence (Fernandez-Arias et al.,
1997; Liu and Vakharia, 2004; Nouen et al., 2012; Escaffre et al.,
2013). While the mechanism is not yet understood, the effect
of VP1 mutations may be related to viral replication, whereas
VP2 has been shown to activate apoptosis via the reduction of
the anti-apoptotic molecule, ORAOV1 (Qin et al., 2017), and
VP5 plays a key role in apoptosis by preventing it early during
infection and by activating it at later time points (Lin et al.,
2015). Virulence is therefore likely to be a complex phenotype,
however, it is possible that the VP4 sequence could contribute
to this. Five of the nine amino acid residues in UK661 that
were different from F52/70 are also found in diverse vv IBDV
strains from different geographical regions, but were not found
in other classical or attenuated strains (31I, 170Y, 175N, 205S,
and 241D) (Supplementary Figure 3A). It is therefore possible
that these amino acids represent a VP4 “genetic signature of
virulence.” We speculate that the enhanced ability to antagonize
innate immune responses is at least partly due to features of
the VP4 from vvIBDV strains. By antagonizing antiviral type I
IFN responses to a greater extent, the VP4 could enhance the
replication of vv strains in the BF and lead to more pathology,
and by antagonizing pro-inflammatory cytokine responses, the
VP4 could hinder protective immune cell infiltration to the
BF, further exacerbating pathology caused by the vv strains.
Moreover, given that the classical strains emerged in the 1960s
and vv strains subsequently emerged in the 1980s, it is tempting
to speculate that vvIBDVs evolved to have a VP4 protein with
an enhanced ability to inhibit NF-κB activation, promoting
increased virus fitness due to suppressed antiviral responses.
Consistent with this hypothesis, the replication of the UK661
virus was significantly enhanced in DT40 cells compared to the
F52/70 virus (Figure 3A), although we did not see a difference in
peak titer between the PBG98-VP4UK661 virus and the PBG98-
VP4F52/70 virus in DF-1 cells, possibly because innate immunity
was not significantly affected until later in the replication cycle of
the chimeric viruses for reasons that remain poorly understood.
The presence of the VP4 protein from the F52/70 IBDV
strain in the cytoplasm of the host cell not only failed to inhibit
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the induction of type I IFN, but actually triggered an innate
immune response (Figure 4), although the molecular basis for
this remains undetermined. It is possible that the VP4 protein
from the UK661 strain either does not trigger the same pathways,
or inhibits the induction of these responses. Consistent with
this, the clinical scores of birds inoculated with the F52/70 virus
were actually higher than birds inoculated with UK661 at 48
hpi (Figure 1B). At first this seems counter-intuitive that the
vv strain would cause less severe symptoms than the classical
strain, however, this may be due to the increased expression
of type I IFN and pro-inflammatory genes in birds inoculated
with the F52/70 virus, as stimulation of these innate immune
responses would be expected to result in clinical signs such as
lethargy, depression, and ruffled feathers as observed to a greater
extent in the F52/70-inoculated group. This further underpins
the complexity of defining virulence and highlights that our
understanding of why some birds reach humane end points,
whereas others do not, remains unknown.
Our study is not without limitations: Gene expression was
quantified by RTqPCR, and only a small panel of genes were
investigated. It would be beneficial in the future to compare
gene expression by RNA-Seq to gain a more comprehensive
comparison of strain-dependent differences in expression.
Never-the less, our dataset does allow us to draw useful
conclusions. Additionally, we only compared the UK661 strain
with the F52/70 strain and it would be interesting to compare
vv, classical, and vaccine strains, and possibly also diverse strains
from different geographical regions, or serotype 1 compared to
serotype 2. However, this was beyond the scope of the current
project. Despite its limitations, our study does provide useful
information that can be used to inform IBDV surveillance efforts
and improve IBDV vaccines: Identifying genetic signatures of
increased IBDV virulence could be used to better inform national
surveillance efforts in order to calculate the potential threat of
an emerging strain as early as possible. Moreover, identifying
genetic signatures of attenuation could be used to engineer
a rationally designed live vaccine candidate. For example, it
might be beneficial to explore the potential, as novel vaccine
candidates, of chimeric viruses engineered with the VP4 gene
from attenuated strains in the backbone of a field strain.
Taken together, our data demonstrate that UK661 induced
the expression of lower levels of anti-viral type I IFN responses
than the classical strain in vitro and in vivo and this was, in
part, due to strain-dependent differences in the VP4 protein. We
speculate that this might enhance viral fitness and contribute to
the enhanced virulence of UK661. This provides new information
that could be used to improve IBDV surveillance efforts and
control strategies.
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